These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9472852)

  • 1. Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression.
    O'Connor M; Silver H
    J Clin Psychopharmacol; 1998 Feb; 18(1):89-91. PubMed ID: 9472852
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.
    Ostroff RB; Nelson JC
    J Clin Psychiatry; 1999 Apr; 60(4):256-9. PubMed ID: 10221288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comments on "Serotonin syndrome during treatment with paroxetine and risperidone".
    Gillman PK
    J Clin Psychopharmacol; 2001 Jun; 21(3):344-5. PubMed ID: 11386501
    [No Abstract]   [Full Text] [Related]  

  • 4. Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases.
    Epperson CN; Fasula D; Wasylink S; Price LH; McDougle CJ
    J Child Adolesc Psychopharmacol; 1999; 9(1):43-9. PubMed ID: 10357517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
    Straton JB; Cronholm P
    J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors plus pindolol. The REEP.
    Bordet R; Thomas P; Dupuis B
    Lancet; 1997 Jul; 350(9073):289. PubMed ID: 9242816
    [No Abstract]   [Full Text] [Related]  

  • 7. SSRIs and tamoxifen. Why condemn fluoxetine?
    Jenkinson ML
    BMJ; 2010 Mar; 340():c1319. PubMed ID: 20219794
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology in the New York Times.
    Kramer TA
    MedGenMed; 2004 Jun; 6(2):26. PubMed ID: 15266252
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Agid O; Lerer B
    J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice guidelines for depression in young people.
    Jureidini JN; Tonkin AL
    Med J Aust; 2003 Mar; 178(6):300; author reply 300-2. PubMed ID: 12633493
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors plus pindolol.
    Isaac MT; Tome MB
    Lancet; 1997 Jul; 350(9073):288-9. PubMed ID: 9242815
    [No Abstract]   [Full Text] [Related]  

  • 13. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
    Farah A
    J Clin Psychiatry; 1999 Apr; 60(4):260-1. PubMed ID: 10221289
    [No Abstract]   [Full Text] [Related]  

  • 14. Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
    Morinobu S; Yamashita H; Yamawaki S; Tanaka K; Ohkawa M
    J Clin Psychiatry; 2002 Sep; 63(9):838-40. PubMed ID: 12363127
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
    Rone LA; Ferrando SJ
    Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
    Polsky D; Onesirosan P; Bauer MS; Glick HA
    J Clin Psychiatry; 2002 Feb; 63(2):156-64. PubMed ID: 11874218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone and paroxetine given singly and in combination for bipolar depression.
    Shelton RC; Stahl SM
    J Clin Psychiatry; 2004 Dec; 65(12):1715-9. PubMed ID: 15641878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.